[HTML][HTML] Position paper on the diagnosis and treatment of peripheral arterial disease (PAD) in people with diabetes mellitus
B Balletshofer, W Ito, H Lawall, N Malyar… - Experimental and …, 2019 - thieme-connect.com
This position paper is based on the current German and international guideline
recommendations [1][2][3] and serves as a short, clinically-oriented guideline for the …
recommendations [1][2][3] and serves as a short, clinically-oriented guideline for the …
A primer on cohort studies in vascular surgery research
Vascular research questions can be answered using various study designs. Observational
studies are used frequently to address a wide range of clinical questions when randomized …
studies are used frequently to address a wide range of clinical questions when randomized …
Survival and causes of death among veterans with lower extremity revascularization with paclitaxel‐coated devices: insights from the veterans health administration
JA Gutierrez, SV Rao, WS Jones… - Journal of the …, 2021 - Am Heart Assoc
BACKGROUND The long‐term safety of paclitaxel‐coated devices (PCDs; drug‐coated
balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used …
balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used …
Editor's Choice–Real World Study of Mortality After the Use of Paclitaxel Coated Devices in Peripheral Vascular Intervention
Objective This observational cohort study examined outcomes after peripheral vascular
intervention (PVI) with paclitaxel coated devices (PCD) and non-PCD, and evaluated …
intervention (PVI) with paclitaxel coated devices (PCD) and non-PCD, and evaluated …
[HTML][HTML] Towards uniform case-identification criteria in observational studies on peripheral arterial disease: A scoping review.
N Keekstra, M Biemond, J van Schaik… - Annals of Vascular …, 2024 - Elsevier
Objective The diagnosis peripheral arterial disease (PAD) is commonly applied for
symptoms related to atherosclerotic obstructions in the lower extremity, though its clinical …
symptoms related to atherosclerotic obstructions in the lower extremity, though its clinical …
[HTML][HTML] No increase in all-cause mortality at 2 years among patients undergoing drug-coated balloon angioplasty
2. Teramoto T, Tsuchikane E, Matsuo H, et al. Initial success rate of percutaneous coronary
intervention for chronic total occlusion in a native coronary artery is decreased in patients …
intervention for chronic total occlusion in a native coronary artery is decreased in patients …
Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients≥ 65 years old: An ACC PVI Registry Analysis
EH Weissler, A Annapureddy, Y Wang… - American heart …, 2021 - Elsevier
Background The connection between paclitaxel-coated devices (PCD) use during
peripheral vascular interventions (PVI) and mortality is debated. We aimed to analyze …
peripheral vascular interventions (PVI) and mortality is debated. We aimed to analyze …
[HTML][HTML] Outcomes of treatment with paclitaxel-coated devices for peripheral arterial disease
Objective The treatment of femoropopliteal peripheral artery disease (PAD) using paclitaxel-
coated devices (PCDs) has been shown to improve patency in several randomized trials …
coated devices (PCDs) has been shown to improve patency in several randomized trials …
[HTML][HTML] Adverse events in primary percutaneous coronary angioplasty with drug-eluting stents compared with drug-coated balloons: a retrospective outlook
HS Khan, J Malik, M Mohsin, A Javed, MU Farooq - Cureus, 2020 - ncbi.nlm.nih.gov
Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents
Compared With Drug-Coated Balloons: A Retrospective Outlook - PMC Back to Top Skip to …
Compared With Drug-Coated Balloons: A Retrospective Outlook - PMC Back to Top Skip to …
Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus–Gemeinsame …
B Balletshofer, D Böckler, H Diener… - Diabetologie und …, 2020 - thieme-connect.com
Dieses Positionspapier basiert auf den aktuellen deutschen und internationalen
Leitlinienempfehlungen [1][2][3] und dient als kurze, klinisch orientierte …
Leitlinienempfehlungen [1][2][3] und dient als kurze, klinisch orientierte …